CIRS and Endotoxins

Persistent inflammation that doesn’t resolve, despite leaving a moldy environment or following treatment protocols, typically signals that more than mycotoxins are involved. One frequently overlooked driver is endotoxins, bacterial toxins known as lipopolysaccharides (LPS) that originate from Gram-negative bacteria. 

 

In individuals with Chronic Inflammatory Response Syndrome (CIRS), these endotoxins can act as ongoing immune triggers, amplifying inflammation long after the initial exposure. This can help explain lingering symptoms in certain cases.

 

In water-damaged buildings, mold rarely exists in isolation. Gram-negative bacteria and their endotoxins often coexist, compounding the inflammatory burden. Meanwhile, endotoxins can also be found in various other sources that require proper resolution. 

 

Understanding the relationship between CIRS and endotoxins expands the root-cause lens beyond mold alone, helping individuals create supportive healing environments and ultimately achieve remission.

 

Key Takeaways

• Endotoxins (lipopolysaccharides, LPS) from Gram-negative bacteria can act as powerful immune triggers that amplify inflammation in Chronic Inflammatory Response Syndrome (CIRS).
• Water-damaged buildings commonly contain a biochemical mix of mold, bacteria, endotoxins, and actinos that can sustain immune dysregulation.
• Endotoxemia and leaky gut may allow LPS to enter circulation, reinforcing neurological, hormonal, and immune symptoms.
• Persistent sinus biofilms, including MARCoNS or Staphylococcus aureus colonization, can contribute to ongoing inflammatory signaling.
• Endotoxins may worsen brain fog, headaches, mast cell activation, insulin resistance, and mitochondrial dysfunction in CIRS patients.
• The gut–immune–brain axis plays a central role in how endotoxin exposure translates into cognitive and systemic symptoms.
• Addressing endotoxins requires a layered approach: removing ongoing exposure, supporting detox pathways, restoring gut integrity, and regulating the nervous system.
• Creating a supportive healing environment is foundational for breaking the inflammatory cycle and achieving long-term remission in CIRS.

 

 

What Is CIRS?

 

 

Chronic Inflammatory Response Syndrome (CIRS) is a multifaceted condition that affects numerous physiological systems, often producing a wide spectrum of seemingly unrelated symptoms. At its foundation is a maladaptive immune response that remains chronically activated, sustaining inflammation long after the original trigger has occurred. This persistent immune signaling can impact neurological, hormonal, digestive, and metabolic function, leaving individuals feeling unwell in ways that are difficult to fully explain.

 

Identifying CIRS requires a more nuanced approach than routine medical evaluations typically provide. Standard blood panels and conventional screenings frequently miss the subtle patterns associated with biotoxin-related illness. Instead, a thorough clinical evaluation, paired with targeted laboratory markers and a detailed environmental and exposure history, is essential to recognize the constellation of findings that point toward CIRS.

 

Since symptoms are commonly diffuse and overlap with other diagnoses, many individuals are misdiagnosed or dismissed altogether. Traditional autoimmune testing may appear normal, prolonging the search for answers. A precise diagnosis depends on specialized testing and practitioner insight to uncover the underlying inflammatory drivers. With that understanding, treatment can shift from surface-level symptom control to restoring immune balance and supporting meaningful, long-term healing.

 

 

In genetically susceptible individuals, CIRS is commonly initiated by biotoxins—substances that provoke an exaggerated and poorly regulated immune response. These inflammatory triggers can arise from multiple environmental and biological exposures, including:

 

• Water-Damaged Indoor Environments: A significant majority of CIRS cases are linked to damp or previously water-damaged buildings. These settings generally contain mold fragments, Gram-negative bacteria, and microbial debris that remain suspended in the air. Importantly, even non-viable (dead) mold particles can stimulate immune activation, contributing to neurological, respiratory, and systemic symptoms.
• Tick-Borne and Vector-Related Infections: Organisms transmitted through insect bites, such as Borrelia burgdorferi (associated with Lyme disease) and Babesia microti, can initiate persistent inflammatory cascades. Certain envenomations, including rare spider bites, have also been documented as potential immune triggers.
• Toxin-Containing Seafood: Reef fish exposed to algal toxins, including ciguatoxins, can accumulate these compounds through the marine food chain. Larger predatory fish pose the highest exposure risk due to bioaccumulation.
• Harmful Algal Blooms in Water Sources: Freshwater and coastal blooms involving cyanobacteria or dinoflagellates (such as Pfiesteria) can release biotoxins into the environment. Exposure may occur through ingestion, inhalation of aerosolized particles, or direct skin contact.
• Additional Environmental and Biological Stressors: Chronic viral infections, certain medical exposures, volatile organic compounds (VOCs), endotoxins, and actinomycetes may further disrupt immune regulation. In those predisposed to CIRS, these cumulative stressors can intensify systemic inflammation and prolong symptom persistence.

 

 

Biotoxins are microscopic, chemically active substances that readily cross cell membranes, allowing them to circulate and disrupt immune signaling in ways that standard laboratory tests may not easily capture. While inhalation of contaminated indoor air, particularly in water-damaged buildings, is a common exposure route, biotoxins can also enter the body through tainted food sources, vector-borne infections, or contact with contaminated water.

 

Importantly, exposure by itself doesn’t automatically result in CIRS. Whether illness develops depends heavily on genetic predisposition and cumulative immune stress. Major physiological events, such as infections, surgical procedures, toxic chemical exposures, pregnancy, or significant psychological stress, can strain immune resilience and provoke the release of inflammatory cytokines. In individuals with certain HLA-DR gene patterns, this heightened immune activation may become the inflection point that shifts the body into a chronic inflammatory state.

 

In many individuals, biotoxins are successfully identified and cleared without lasting impact. However, in genetically vulnerable individuals, the immune system struggles to properly recognize and eliminate these compounds. As a result, toxins may remain in circulation, perpetuating inflammation and multi-system symptoms. Biotoxin-related illness can emerge abruptly or progress gradually, often without a clear triggering moment.

 

For a more detailed understanding of CIRS, click here.

 

Pro-Tip: If you think you’re suffering from CIRS, you can learn more about CIRS diagnostic testing here.

 

What Is the Shoemaker Protocol?

 

 

Developed by Dr. Ritchie Shoemaker, the Shoemaker Protocol is a structured, peer-reviewed treatment framework for CIRS and related biotoxin illnesses. Rather than masking symptoms, it follows a deliberate sequence designed to interrupt the inflammatory cascade and correct the immune dysfunction driving the condition.

 

The first and most critical step is identifying and eliminating ongoing exposure. Without removing the source of inflammatory triggers, the immune system remains locked in activation, making progress nearly impossible. While mold is a common focus, endotoxins from Gram-negative bacteria are an equally important part of this conversation. In water-damaged buildings, mold, bacterial fragments, and endotoxins frequently coexist, continuing to stimulate immune pathways even after mold concerns are addressed. If endotoxin exposure persists, the inflammatory cycle can remain active.

 

After exposure has been addressed, targeted binders such as cholestyramine (CSM) or Welchol are used to interrupt toxin recirculation through the bile, helping reduce systemic immune activation. Subsequent steps focus on correcting abnormal inflammatory markers, restoring hormonal balance, and stabilizing immune signaling before considering therapies like Vasoactive Intestinal Peptide (VIP), which is introduced only when laboratory markers indicate readiness.

 

Actinomycetes, often referred to as actinos, are another potential contributor in some water-damaged environments. However, their role is complex and highly nuanced. We won’t explore actino-specific protocols in depth here, as that topic requires careful clinical context. For a detailed discussion of our clinical perspective and approach, see our in-depth article on actinos and CIRS.

 

When the foundational steps are handled thoroughly, the body is far more capable of recalibrating immune function and moving toward durable remission.

 

What Are Endotoxins?

 

 

Endotoxins are toxic substances that are part of certain types of bacteria. Unlike some toxins that are actively released by bacteria, endotoxins are built into the outer structure of the bacterial cell itself. When these bacteria break apart or die, endotoxins are released into the surrounding environment, where they can trigger a strong immune response.

 

The most well-known type of endotoxin is called lipopolysaccharide (LPS). LPS is found in the outer membrane of Gram-negative bacteria, a category of bacteria defined by the structure of their cell wall. The term “lipopolysaccharide” describes its makeup:

 

• Lipo- refers to fat (lipid)
• Poly- means many
• Saccharide refers to sugar

 

In simple terms, LPS is made of fat and sugar molecules linked together in a way that makes it highly recognizable to the immune system. When LPS enters the body or bloodstream, the immune system sees it as a danger signal. This can trigger the release of inflammatory chemicals designed to protect the body. In small amounts, this response is protective. In larger or ongoing amounts, it can contribute to chronic inflammation.

 

It’s also important to understand the difference between endotoxins and exotoxins.

 

• Endotoxins are part of the bacterial cell wall and are released when the bacteria break down.
• Exotoxins are toxins that bacteria actively produce and secrete while they are alive.

 

Exotoxins are typically highly specific in how they affect the body, targeting certain tissues or functions. Endotoxins, on the other hand, tend to trigger a broader immune response, activating inflammation throughout the body.

 

The Link Between CIRS and Endotoxins

 

 

Endotoxins play a significant role in CIRS. While mold and other biotoxins are commonly discussed, endotoxins can act as powerful amplifiers of the immune dysfunction already present in CIRS. Since they strongly activate inflammatory pathways, even low-level or ongoing exposure may keep the immune system in a heightened state of reactivity. 

 

We’ll explore the specific mechanisms through which endotoxins influence immune signaling, gut integrity, neurological symptoms, and overall disease persistence.

 

Endotoxins as an Ongoing Immune Trigger

 

 

One of the reasons endotoxins are so impactful in CIRS is that they activate the same core inflammatory pathways triggered by other biotoxins. In other words, endotoxins follow the same immune signaling cascade that keeps CIRS active and self-perpetuating.

 

When lipopolysaccharide (LPS) enters the body, it binds to a receptor on immune cells called Toll-like receptor 4 (TLR4). TLR4 acts like a security alarm for the innate immune system. Its job is to recognize danger signals from bacteria and initiate a defense response. In healthy situations, this response is short-lived and protective. In CIRS, however, the alarm system doesn’t properly shut off.

 

Once TLR4 is activated, it triggers an intracellular signaling pathway that leads to activation of nuclear factor kappa B (NF-κB). NF-κB is often described as a master switch for inflammation. When turned on, it enters the cell nucleus and instructs the cell to produce inflammatory molecules.

 

This activation sets off a cytokine cascade, including increased production of inflammatory messengers such as:

 

• Interleukin-1 (IL-1)
• Interleukin-6 (IL-6)
• Tumor Necrosis Factor-alpha (TNF-α)

 

These cytokines are essential for fighting infections in the short term. But when produced in excess or for prolonged periods, as seen in CIRS, they drive widespread immune activation, vascular changes, and tissue-level inflammation.

 

The result is an amplification of systemic inflammation. 

 

Since endotoxins use the same biotoxin pathway as mold toxins and other triggers, their presence can reinforce and magnify the inflammatory loop already present in CIRS. Even low-level, ongoing exposure may keep TLR4 and NF-κB signaling active, sustaining abnormal lab markers and perpetuating symptoms across multiple body systems.

 

For this reason, endotoxins are fully integrated into the same immune dysregulation pathway that defines CIRS.

 

Endotoxemia and Leaky Gut in CIRS

 

 

Endotoxemia refers to the presence of endotoxins, specifically lipopolysaccharide (LPS), in the bloodstream. Under normal conditions, LPS remains contained inside the gut, safely separated from circulation by a tightly regulated intestinal barrier. In individuals with CIRS, however, this barrier is often compromised, allowing endotoxins to pass into the bloodstream and trigger widespread inflammation.

 

One major contributor to this breakdown is increased intestinal permeability, commonly referred to as leaky gut. In CIRS, low levels of melanocyte-stimulating hormone (MSH), a hallmark lab finding, play an important role. MSH helps regulate immune balance, maintain mucosal integrity, and support the tight junctions that hold intestinal cells together. When MSH is suppressed, the gut lining becomes more vulnerable, making it easier for inflammatory compounds like LPS to cross into circulation.

 

This process is known as LPS translocation. Once LPS enters the bloodstream, it activates TLR4 and downstream inflammatory pathways, amplifying systemic immune activation. The result isn’t just localized gut inflammation, but body-wide effects that can worsen brain fog, fatigue, joint pain, and hormonal disruption.

 

Dysbiosis, or microbial imbalance in the gut, further compounds the problem. When beneficial bacteria are depleted and Gram-negative bacteria are overrepresented, LPS production increases. Combined with a weakened gut barrier, this creates a cycle of endotoxin leakage and immune stimulation.

 

Bile acid dysfunction adds another layer. Bile helps bind and escort toxins, including LPS, out of the body through stool. In CIRS, impaired bile flow or recirculation issues can reduce effective toxin clearance, allowing endotoxins to persist longer in the system. This combination of leaky gut, dysbiosis, low MSH, and impaired detoxification creates a feedback loop that sustains endotoxemia and perpetuates chronic inflammation.

 

Endotoxins in Water-Damaged Buildings

 

 

Water-damaged buildings rarely contain just one type of contaminant. When moisture accumulates behind walls, under flooring, or within HVAC systems, it creates an ideal environment not only for mold growth but also for bacteria and actinos. Gram-negative bacteria thrive in damp conditions, and as they grow and break down, they release endotoxins, specifically lipopolysaccharides (LPS), into the surrounding environment.

 

Over time, this leads to what many experts describe as a biochemical stew: a mixture of mold spores, mycotoxins, bacterial fragments, endotoxins, microbial volatile organic compounds (mVOCs), and actino byproducts. These particles can become airborne, especially when disturbed, increasing the likelihood of inhalation and immune activation in susceptible individuals.

 

Endotoxins and mold mycotoxins can also have synergistic effects. While they are structurally different, both activate inflammatory pathways within the innate immune system. Endotoxins strongly stimulate TLR4 signaling, while certain mycotoxins disrupt immune regulation and oxidative balance. When present together, they can amplify cytokine production, worsen barrier dysfunction, and intensify systemic inflammation beyond what either would cause alone. For individuals with CIRS, this combined exposure can further entrench immune dysregulation and prolong symptoms.

 

Proper remediation performed under the Surviving Mold Indoor Environmental Professional (IEP) Consensus Statement for Microbial Remediation is designed to address both mold growth and associated microbial contaminants, including endotoxins. In many cases, thorough remediation can significantly reduce endotoxin burden related to building exposure. However, water-damaged environments are not the only possible source of endotoxins, and additional contributors may need to be considered.

 

Troubleshooting Other Sources of Endotoxins

 

 

While water-damaged buildings are a major source of exposure, endotoxins are not limited to moldy environments. Lipopolysaccharides (LPS) are part of Gram-negative bacteria, which are common in everyday life. For individuals with CIRS or ongoing immune dysregulation, identifying and reducing these additional exposures can be an important part of breaking the inflammatory cycle.

 

Below are other potential sources of endotoxins to consider:

 

• Contaminated Food: Improperly handled or contaminated food can expose individuals to Gram-negative bacteria, particularly in cases of foodborne illness.
• Water Sources: Drinking or bathing in contaminated water, especially from compromised plumbing systems or untreated sources, can introduce bacterial fragments and endotoxins.
• Sewer Gas and Plumbing Issues: Leaks, cracked sewer lines, or dry plumbing traps (such as unused sinks or floor drains) can allow sewer gases and aerosolized bacteria into indoor air.
• Cat Litter Boxes and Diapers: Concentrated waste environments contain high levels of bacteria. Changing diapers or cleaning litter boxes may increase exposure, particularly in enclosed or poorly ventilated spaces. Pets, particularly cats and dogs, can also be a source of indoor endotoxins as they can introduce bacteria from the outdoors and directly shed them. 
• Outdoor and Agricultural Exposure: Contact with agricultural soil, manure, compost, farm environments, picking up dog waste, or spending time in areas with high bacterial load can increase inhalational or contact exposure. 
• Dental Procedures or Periodontal Disease: Manipulation of the gums during dental work or chronic gum infections can allow bacteria and LPS to enter the bloodstream transiently.
• Medical Devices: Improperly sterilized catheters, implants, or other medical equipment that contact bodily fluids can introduce bacterial fragments.
• Industrial or Waste-Heavy Environments: Certain occupational settings, including waste management or agricultural facilities, can have elevated airborne bacterial components.
• Chronic or Acute Bacterial Infections: Gram-negative organisms such as E. coli, Salmonella, Pseudomonas aeruginosa, and Bartonella release LPS. Ongoing sinus infections, urinary tract infections, gastrointestinal infections, or vector-borne infections can contribute to persistent endotoxin exposure.
• Gut Dysbiosis: An overgrowth of Gram-negative bacteria in the intestines increases internal LPS production, especially when intestinal permeability is elevated.

 

Since endotoxins can originate from both internal (gut, infections) and external (environmental) sources, troubleshooting usually requires looking beyond mold alone. 

 

The Endotoxin Hypothesis of Alzheimer’s

 

 

CIRS is increasingly viewed not only as a multi-system inflammatory condition, but as a potential upstream contributor to neurodegenerative disease, including Alzheimer’s. At its core, CIRS involves persistent innate immune activation, elevated inflammatory cytokines, blood–brain barrier vulnerability, and chronic microglial stimulation. These same mechanisms are now recognized as central drivers in Alzheimer’s disease, suggesting that CIRS may represent one of the root inflammatory pathways that increase long-term cognitive risk.

 

The endotoxin hypothesis of Alzheimer’s disease, detailed in the May 2024 review, proposes that lipopolysaccharide (LPS) from Gram-negative bacteria may directly contribute to Alzheimer’s pathology. The review highlights several important findings:

 

• Higher levels of LPS have been detected in the blood and brain tissue of individuals with Alzheimer’s disease
• LPS strongly activates microglia, increasing inflammatory cytokines and sustaining neuroinflammation 
• Experimental models show LPS exposure increases amyloid-β (Aβ) production and aggregation and promotes tau phosphorylation, the two hallmark pathological features of Alzheimer’s 
• LPS may disrupt the blood–brain barrier, allowing peripheral inflammation to more easily influence brain tissue 
• Even low-dose systemic LPS exposure has been associated with memory impairment and cognitive changes in both animal and human studies 

 

The authors outline a sequence in which LPS exposure may increase amyloid deposition, prime microglia, accelerate tau pathology, and ultimately contribute to synaptic dysfunction and neurodegeneration. They also suggest that reducing LPS burden may help slow disease progression.

 

This model closely mirrors what is seen in CIRS. 

 

Individuals with CIRS commonly exhibit endotoxemia, dysbiosis, impaired barrier integrity, and chronically elevated inflammatory markers. If circulating LPS can access or influence the brain, persistent endotoxin exposure may serve as a mechanistic bridge between systemic inflammatory illness and Alzheimer’s pathology.

 

While Alzheimer’s disease is multifactorial and influenced by genetics, metabolism, diet, lifestyle, and environmental exposures, CIRS represents a chronic inflammatory state that may sit upstream of these processes. By sustaining innate immune activation and microglial priming over time, CIRS may help create the biological conditions in which neurodegeneration becomes more likely, making early identification and treatment of endotoxin burden a potentially important strategy for protecting long-term brain health.

 

Why Endotoxins Worsen CIRS Symptoms

Endotoxins can significantly intensify the symptom burden in CIRS because they activate the same inflammatory pathways already dysregulated in the condition. Stimulating innate immune receptors and amplifying cytokine signaling reinforces systemic inflammation, disrupts barrier integrity, and strains detox pathways. 

 

Let’s break down how endotoxins specifically worsen neurological symptoms, immune dysfunction, and hormonal and metabolic imbalances in CIRS.

 

Neurological Symptoms

 

 

Endotoxins can significantly affect the brain and nervous system in individuals with CIRS. Many patients describe brain fog as slowed thinking, poor word recall, difficulty concentrating, or feeling mentally offline. This can occur when inflammatory signals alter neurotransmitter balance, reduce cerebral blood flow, and interfere with efficient communication between brain cells.

 

Headaches are also common and can stem from vascular inflammation, increased nitric oxide signaling, and heightened sensory sensitivity. Some individuals notice pressure-type headaches, while others experience migraine-like patterns triggered by environmental or stress exposures.

 

At the core of these symptoms is neuroinflammation. When immune messengers circulate at elevated levels, they can activate microglia, the brain’s immune cells, shifting them into a more reactive state. Over time, this can disrupt synaptic signaling, sleep architecture, and mood regulation.

 

The vagus nerve also plays an important role. As the main communication highway between the gut, immune system, and brain, vagal signaling can become impaired when inflammation is persistent. Reduced vagal tone can contribute to dizziness, heart rate variability changes, digestive disruption, and heightened sensitivity to stress—all of which are commonly reported in CIRS.

 

Pro-Tip: Anecdotally, some of our CIRS patients and clients have noticed different symptom manifestation from endotoxin exposure compared to mold exposure. Tracking these differences can help with troubleshooting and pinpointing potential exposure concerns. 

 

Immune Dysregulation

 

 

Endotoxins can further destabilize an already dysregulated immune system in CIRS. Many patients demonstrate elevations in inflammatory markers such as complement component 4a (C4a), transforming growth factor beta 1 (TGF-β1), and matrix metalloproteinase-9 (MMP-9), which reflect complement activation, immune signaling imbalance, and vascular inflammation. Persistent endotoxin exposure can help sustain these abnormal lab patterns.

 

Mast cell activation may also intensify. Endotoxins can indirectly stimulate mast cells, increasing histamine release and contributing to flushing, itching, sinus congestion, food sensitivities, and chemical reactivity. This can create a cycle where environmental triggers provoke exaggerated immune responses.

 

For some individuals, this heightened immune activation can also provoke autoimmune flares. When inflammatory signaling remains elevated, immune tolerance can weaken, increasing the likelihood that the body mistakenly targets its own tissues. This may present as worsening joint pain, thyroid antibodies, or flares of previously stable autoimmune conditions.

 

Hormonal and Metabolic Effects

 

 

Chronic endotoxin-driven inflammation can ripple into endocrine and metabolic systems. One common consequence is insulin resistance. Inflammatory cytokines can interfere with insulin signaling at the cellular level, contributing to blood sugar instability, energy crashes, and difficulty maintaining metabolic flexibility.

 

The stress axis can also become disrupted. Persistent immune activation can alter hypothalamic-pituitary-adrenal (HPA) axis signaling, leading to cortisol dysregulation. Some individuals experience elevated evening cortisol and wired-but-tired patterns, while others may show flattened cortisol rhythms and low stress resilience.

 

Thyroid suppression can occur when inflammation reduces conversion of T4 to active T3 or increases reverse T3 production. This may contribute to cold intolerance, hair thinning, slowed metabolism, and persistent fatigue, even when basic thyroid labs appear within range.

 

Finally, endotoxins can impair mitochondrial function, reducing the efficiency of cellular energy production. Mitochondria are highly sensitive to oxidative stress and inflammatory signaling. When energy production declines, patients may experience significant fatigue, exercise intolerance, and delayed recovery after minor exertion.

 

Together, these neurological, immune, and metabolic disruptions help explain why endotoxins can dramatically amplify the symptom intensity of CIRS, even when the original trigger has already been addressed.

 

The Gut-Immune Brain Axis in CIRS and Endotoxemia

 

 

CIRS disrupts the communication between the gut, immune system, and brain, commonly called the gut–immune–brain axis. When lipopolysaccharide (LPS) enters circulation, it can destabilize all three systems at once, reinforcing inflammation and neurological symptoms.

 

How LPS Drives Microglial Activation

Microglia are the brain’s immune cells. When exposed to inflammatory signals linked to LPS, they shift into a reactive state and release cytokines that affect mood, cognition, and sensory processing. In CIRS, microglia can remain primed, meaning they overreact to stressors, contributing to brain fog, anxiety, and heightened sensitivity.

 

Blood-Brain Barrier Permeability

Inflammation can weaken the blood–brain barrier (BBB), making it more permeable. While this doesn’t mean toxins freely enter the brain, it does lower the threshold for inflammatory signaling to influence brain tissue. In CIRS, systemic inflammation can therefore more easily translate into neurological symptoms.

 

Histamine and Mast Cell Cross-Talk

LPS can indirectly stimulate mast cells, increasing histamine release. Since mast cells are active in the gut, respiratory tract, and near the BBB, this activation can amplify flushing, headaches, insomnia, and food or chemical sensitivities, all common complaints in CIRS.

 

Nervous System Dysregulation Amplification

Ongoing inflammation can suppress vagal tone and push the nervous system toward sympathetic dominance. As autonomic regulation declines, the body becomes less efficient at calming immune responses, perpetuating a cycle of endotoxemia, stress reactivity, and multi-system flares.

 

MARCoNS, Staph Colonization, Biofilms, and Exotoxin Production

 

 

In individuals with CIRS, chronic nasal colonization is common. Patients typically test positive for either Multiple Antibiotic Resistant Coagulase Negative Staphylococci (MARCoNS) or Staphylococcus aureus colonization in the sinuses. While these are different organisms, both can contribute to ongoing immune activation in susceptible individuals.

 

Under normal circumstances, certain strains of staphylococci occupy nasal real estate and help prevent more pathogenic organisms from taking hold. In theory, stable staph colonization may limit the development of MARCoNS. However, in clinical practice, this balance is not always predictable, as we’ve seen disrupted nasal ecosystems in CIRS patients where either MARCoNS, S. aureus, or both are contributing to persistent inflammation.

 

Unlike Gram-negative bacteria, staph species don’t produce endotoxin (LPS). However, both MARCoNS and S. aureus are considered Gram-positive bacteria and can produce a wide range of exotoxins, including enterotoxins and superantigens, which can strongly stimulate the immune system. These exotoxins can provoke cytokine release, mast cell activation, and heightened immune reactivity, particularly in individuals whose immune systems are already dysregulated.

 

Both MARCoNS and S. aureus are also capable of forming biofilms, which protect bacteria within a structured matrix that limits immune clearance and reduces antibiotic effectiveness. Biofilms allow microbes to persist in the sinuses, continually releasing inflammatory signals over time. Even if systemic endotoxin exposure has been addressed, chronic nasal biofilm activity can act as a localized but ongoing inflammatory driver.

 

 

Dr. Musto of MicrobiologyDX has recommended that symptomatic staph colonization shouldn’t be ignored. When patients present with any multi-system symptoms or persistently elevated inflammatory markers at a certain point of the Shoemaker Protocol, targeted treatment may be warranted. The goal isn’t to sterilize the microbiome, but to reduce pathogenic overgrowth and restore microbial balance.

 

In the broader context of CIRS, nasal biofilms represent another potential source of immune stimulation, whether through endotoxin-producing Gram-negative bacteria elsewhere in the body or exotoxin-producing staph species in the sinuses. Addressing these reservoirs thoughtfully and strategically can be an important step in reducing total inflammatory burden and supporting more complete recovery.

 

Addressing Endotoxins in CIRS

Reducing endotoxin burden in CIRS requires a more strategic, layered process. The goal is to remove ongoing exposure, support effective toxin clearance, restore barrier integrity, and stabilize immune regulation. 

 

Let’s walk through the foundational steps that help lower endotoxin-driven inflammation and support lasting recovery.

 

Remove Ongoing Exposure

 

 

The first step in addressing endotoxins in CIRS is eliminating ongoing exposure. If inflammatory triggers remain present in the environment, the immune system can’t fully calm down. Proper remediation, performed according to the established Surviving Mold Indoor Environmental Professional (IEP) Consensus Statement for Microbial Remediation, is essential for resolving mold, bacterial contamination, and associated endotoxins in water-damaged buildings. Remediation should address removing mold and resolving underlying moisture sources, contaminated materials, and fine particulate debris that can continue to circulate in indoor air.

 

Beyond structural remediation, it is equally important to consider other environmental sources of endotoxins.

 

Water Sources

In some communities, treated wastewater is recycled into the municipal drinking supply. While regulated, this process can still introduce higher microbial byproducts compared to pristine water sources. For individuals with CIRS, minimizing endotoxin exposure from water can be supportive. A practical solution is installing a whole-home filtration system that includes carbon filtration before reverse osmosis (RO). Carbon helps remove organic compounds and chlorine, protecting the RO membrane and improving overall filtration efficiency. Systems should be sanitized regularly to prevent bacterial and mold buildup within filters and storage tanks, which can otherwise become a secondary source of contamination.

 

Sewer Gas and Plumbing Issues

Leaks, cracked sewer lines, or dry plumbing traps can allow sewer gases and aerosolized bacterial fragments, fungi, endotoxins, and dust into the home. If sewer odor is present or unexplained symptoms persist, consider a professional smoke test to identify hidden leaks. Choose companies that use non-toxic smoke formulations without zinc chloride or added fragrance. Ensure all P-traps (under sinks, floor drains, showers) are maintained and filled with water; for drains that are rarely used, adding a small layer of mineral oil can slow evaporation. Keeping the toilet lid closed before flushing can also help reduce aerosolized bacterial spread. Consider replacing toilet cleaning brushes and plungers more frequently as well. Addressing these plumbing details can meaningfully lower microbial exposure.

 

Cat Litter Boxes and Diapers

Animal waste and diapers contain high concentrations of bacteria. To reduce airborne exposure, consider placing litter boxes in a garage or outdoor area when feasible. Running a high-quality HEPA air purifier near the litter box can help capture particulates. Waste should be scooped frequently and disposed of directly into an outdoor trashcan. Similar practices apply to diaper disposal—using sealed containers indoors only temporarily and transferring waste outside promptly. An air purifier in nursery or diaper-changing areas can further reduce airborne microbial fragments.

 

Outdoor and Agricultural Exposure

Individuals living near farms, livestock operations, or areas with heavy manure use can experience higher background endotoxin exposure. Practical measures include running multiple high-quality air purifiers throughout the home, not wearing shoes inside, keeping windows closed during high-exposure periods, and ensuring proper HVAC filtration. In some cases, limiting outdoor air exchange during peak agricultural activity may be appropriate. If you have dogs, cats, or other pets that are both outdoor and indoor, wiping down their paws after spending time outdoors can also help reduce endotoxin exposure. 

 

Since exposure patterns vary widely, working with a knowledgeable CIRS-trained IEP can help determine personalized, case-by-case solutions.

 

Removing ongoing exposure creates the foundation upon which all other CIRS interventions can work more effectively.

 

Support Detox Pathways

 

 

Once ongoing exposure has been removed, the next priority is improving toxin clearance. In the Shoemaker framework, prescription bile acid sequestrants such as cholestyramine (CSM) and Welchol are used to bind biotoxins in the gut and interrupt enterohepatic recirculation. While traditionally discussed in the context of mold toxins, these binders can also help capture inflammatory compounds associated with endotoxin exposure.

 

Many practitioners also incorporate natural binders either alongside prescription binders or after completing that phase of treatment. Activated charcoal, for example, has been shown to bind endotoxins and other microbial byproducts. Different binders have different affinities, so layering strategically can broaden detox coverage.

 

Phosphatidylcholine (PC), oral or IV, may be used as part of lipid replacement therapy to support cell membrane repair and bile flow. High-dose omega-3 fatty acids (such as Omaprem SPM or fish oil) can also support membrane integrity and reduce inflammatory signaling, helping some patients tolerate binders more comfortably.

 

Optimizing liver function and bile flow is equally important. Hydration, adequate dietary fat (when tolerated), and practitioner-guided liver support can enhance the body’s ability to package and eliminate toxins.

 

Finally, regular bowel movements are essential. While some individuals experience constipation with binders, others may develop loose stools. The goal is consistent elimination, ideally daily or at least every other day, to prevent toxin reabsorption and support effective clearance.

 

Closing Thoughts on CIRS and Endotoxins

For many individuals with CIRS, creating a truly supportive healing environment can feel like the hardest part of the entire journey. It can require time, resources, and a level of troubleshooting that most people never expected to face. 

 

But as frustrating as it can be, this step is also foundational. 

 

If the body is still being exposed to inflammatory triggers, the immune system may not have the safety and stability it needs to downshift, especially during active treatment. 

 

We also understand how overwhelming it can feel to realize there may be multiple exposure points to consider. That can easily spiral into fear, hypervigilance, and a sense that healing is out of reach. However, the goal is to replace fear with clarity—to reframe exposure concerns through a lens of knowledge, pattern recognition, and empowerment.

 

When you understand what drives your symptoms, you regain leverage. Each layer you identify isn’t a reason to panic, but is another lever to pull, another opportunity to support your nervous system, lighten the inflammatory load, and help your body move forward. For patients who are still symptomatic or hitting roadblocks in treatment, endotoxins may be one of the missing pieces that finally explains why progress has stalled.

 

Most importantly, none of this means your body is broken. It means your body has been doing its best to survive in a high-inflammatory environment. With the right support, the right sequencing, and a plan that addresses both biology and regulation, healing is possible. Step by step, you can build a safer internal and external terrain and move toward true remission with far more confidence and hope.

 

Work With Our Trusted CIRS Functional Medicine Practitioners

Our Empower Functional Health practice is honored to be trusted CIRS functional practitioners, supporting patients and clients from around the globe. We’re passionate about helping individuals achieve root-cause healing in order to live the life they are meant to, nearly symptom-free. We provide environmental illness thought leadership and evidence-based insights, paired with clinical pearls, to help you achieve your wellness goals. We welcome you to explore our free resources, and if you find that self-troubleshooting falls short, we’re here to guide you with personalized support and protocols. If you’re interested in working one-on-one with our CIRS functional team for your environmental illness healing journey, our CIRS Discovery Call is the best place to begin.

 

 

DISCLAIMER: This content is for educational purposes only. While we are board-certified in holistic nutrition and are functional practitioners, we are not providing medical advice. Whenever you start a new diet or protocol, always consult with your trusted practitioner first.